Maze Therapeutics CEO Jason V Coloma Reports Disposal of $1.04 Million in Common Shares

PUBT · 19h ago
Maze Therapeutics CEO Jason V Coloma Reports Disposal of $1.04 Million in Common Shares
  • Maze Therapeutics CEO and director Jason V. Coloma sold 34,501 common shares on Nov. 2, 2026.
  • Weighted-average sale prices ranged from $30.095 to $31.0528 per share.
  • Reported holdings totaled 186,901 shares through Coloma Family Trust and 12,965 through The Coloma 2021 Irrevocable Trust.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001676170-26-000026), on November 04, 2026, and is solely responsible for the information contained therein.